Managing knowledge assets under conditions of radical change: The case of the pharmaceutical industry

Technovation

Volumn 31, Issue 2-3, 2011, Pages 105-117

  Allarakhia, Minna ^a   Walsh, Steven ^b  

^a UNIVERSITY OF WATERLOO   (Canada)

^b UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

Biology; Chemistry; Entrepreneurship; Intellectual property; Knowledge management; Nanotechnology; Technology

Indexed keywords

CASE STUDY METHODOLOGIES; COMPETITIVE ADVANTAGE; COMPUTATIONAL SCIENCE; ENTREPRENEURSHIP; INSTITUTIONAL KNOWLEDGE; INTELLECTUAL PROPERTY MANAGEMENT; KNOWLEDGE ASSETS; KNOWLEDGE MANAGEMENT LITERATURE; MANAGEMENT TECHNIQUES; PHARMACEUTICAL FIRMS; PHARMACEUTICAL INDUSTRY; SMALL AND MEDIUM ENTERPRISE; TECHNOLOGICAL DEVELOPMENT; TRANSITION POINT;

BIOLOGY; COMPETITION; DRUG PRODUCTS; INDUSTRY; INTELLECTUAL PROPERTY; INTERNATIONAL LAW; NANOTECHNOLOGY;

KNOWLEDGE MANAGEMENT;

EID: 78751643946     PISSN: 01664972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.technovation.2010.11.001     Document Type: Article

References (150)

1. M. Allarakhia Developing a framework for understanding and enabling open source drug discovery Expert Opinion on Drug Discovery 5 8 2010 709 714
2. M. Allarakhia, D.M. Kilgour, and D. Fuller Modeling the incentive to participate in open source biopharmaceutical innovation R&D Management 40 1 2010 50 66
3. C. Antonelli Knowledge complementarity and fungeability: Implications for regional strategy Regional Studies 37 2003 595 606
4. A. Arora, and A. Fosfuri Licensing the market for technology Journal of Economic Behavior & Organization 52 2003 277 295
5. P. Atkinson, C. Batchelor, and E. Parsons Trajectories of collaboration and competition in a medical discovery Science, Technology and Human Values 23 1998 259 284
6. Berndt, E., Bui, L.T., Reiley, D., Urban, G.A., 1994. The roles of marketing, product quality and price competition in the growth and composition of the US anti-ulcer drug industry. National Bureau of Economic Research Working Paper no. 4904, Cambridge, MA.
7. Beta cell boostVUMC team takes leadership role in international consortium to understand pancreatic development. The Reporter, May 2002.
8. Bianchi, M., Cavaliere, A., Chiaroni, D., Frattini, F., Chiesa, V., 2011. Organizational modes for open innovation in the bio-pharmaceutical industry: an exploratory approach. Technovation 31 (1) 2233.
9. D. Blumenthal Academicindustry relationships in the life sciences: extent, consequences, and management Journal of the American Medical Association 268 1992 3344 3349
10. D. Blumenthal, N. Causino, and E.G. Campbell Academicindustry research relationships in genetics: a field apart Nature Genetics 16 1997 104 108
11. P. Boardman Beyond the stars: the impact of affiliation with university biotechnology centers on the industrial involvement of university scientists Technovation 28 2008 291 297
12. P. Boardman, and B. Ponomarioy University researchers working with private companies Technovation 29 2009 142 153
13. D. Bonn International consortium SNPs away at individuality The Lancet 353 1999 1684
14. J.D. Bower, and E. Whittaker Global R&D networks: the case of the pharmaceutical industry Journal of Industry Studies 1 1992 50 63
15. Broad, Novartis announce diabetes initiative. MIT News, October 2004.
16. D.L. Burk, and M.A. Lemley Biotechnologys uncertainty principle F.S. Kieff, Perspectives on Properties of the Human Genome Project 2003 Elsevier Academic Press San Diego, CA 305 353
17. D.A. Chokshi, M. Parker, and D.P. Kwiatkowski Data sharing and intellectual property in a genomics epidemiology network: policies for large-scale research collaboration Bulletin of the World Health Organization 84 2006 382 387
18. R.H. Coase The problem of social cost Journal of Law and Economics 3 1960 1 44
19. M. Coccia, and S. Rolfo Strategic change of public research units in their scientific activity Technovation 28 2008 485 494
20. Consortium for Functional Glycomics awarded 40.7 million glue grant. Scripps Research Institute, September 2007.
21. K. Davies Cracking the Genome: Inside the Race to Unlock the Human DNA 2001 The Free Press New York, NY
22. K. Devine Cell signaling alliance gets under way The Scientist 2000 14
23. J. Drews In Quest of Tomorrows Medicine 1998 Springer-Verlag New York, NY
24. G. Dutfield Intellectual Property Rights and the Life Sciences Industries: A Twentieth Century History 2003 Ashgate Publishing Limited Burlington, VT
25. R.S. Eisenberg Intellectual property issues in genomics Trends in Biotechnology 14 1996 302 307
26. K.M. Eisenhardt Building theories from case study research Academy of Management Review 14 1989 532 550
27. Expression Project for Oncology (expO) completes first phase of standardized gene expression analyses. International Genomics Consortium, January 2005.
28. D. Foray The Economics of Knowledge 2004 MIT Press Cambridge, MA
29. Genedata collaborates with HepatoSys Systems Biology Competence Network. Genedata, July 2006.
30. V.A. Gilsing, and G.M. Duysters Understanding novelty creation in exploratory networksstructural and relational embeddedness jointly considered Technovation 28 2008 812 817
31. R.M. Grant, and C. Baden-Fuller A knowledge accessing theory of strategic alliances Journal of Management Studies 41 1 2004 61 84
32. A.J. Groen, I.A.M. Wakee, and P.C. De Weerd-Nederhof Managing tensions in a high-tech start-up: an innovation journey in social system perspective International Small Business Journal 26 2008 57 81
33. C. Gross, and J. Allen Technology Transfer for Entrepreneurs: A Guide to Commercializing Federal Laboratory Innovations 2003 Praeger Publishing Westport, CT
34. R. Gulati, and H. Singh The architecture of cooperation: managing coordination costs and appropriation concerns in strategic alliances Administrative Science Quarterly 43 1998 781 814
35. M.A. Heller, and R.S. Eisenberg Can patents deter innovation? The anticommons in biomedical research Science 280 1998 698 701
36. S. Hilgartner Access to data and intellectual property: scientific exchange in genome research Intellectual Property Rights and Research Tools in Molecular Biology 1996 National Academy Press Washington, DC pp. 2839
37. S. Hohmann The Yeast systems biology to unravel the network of life Current Opinion in Biotechnology 16 2005 356 360
38. Hood, L.E., 2000. The university office of technology transfer: the inventor/researchers view. CASRIP Symposium Publication Series 5, CASRIP, University of Washington, Seattle, WA.
39. A.R. Horwitz, N. Watson, and J.T. Parsons Breaking barriers through collaboration: the example of the Cell Migration Consortium Genome Biology 3 2002 1 4
40. K. Hoyle, and F. Pries Repeat commercializers, the habitual entrepreneurs of the universityindustry technology transfer Technovation 29 2009 682 689
41. J. Hunter, and S. Stephens Is open innovation the way forward for big pharma? Nature Review Drug Discovery 9 2010 87 88
42. T.T. Ideker, L. Galitski, and L.E. Hood A new approach to decoding life: systems biology Annual Review Genomics and Human Genetics 2 2001 343 372
43. IMEx consortium provides new mechanism for improving access to molecular interaction data. EMBL-EBI, August 2005.
44. International HapMap Consortium widens data access. NIH News, December 2004.
45. P.A. Jones, and R. Martienssen A blueprint for a Human Epigenome Project: the AACR Human Epigenome workshop Cancer Research 65 2005 11241 11246
46. J. Kaiser Synthetic biology: attempt to patent artificial organism draws a protest Science 316 2007 1557
47. M. Kautt, S. Walsh, and K. Bittner Global distribution of micronano technology and fabrication centers: a portfolio analysis approach Technology Forecasting and Social Change 74 2007 1697 1717
48. S.F. Kieff, 2003 Elsevier Academic Press San Diego, CA
49. H. Kitano Systems biology: a brief overview Science 295 2002 1662 1664
50. H. Kitano Systems biology: toward systems-level understanding of biological systems H. Kitano, Foundation of Systems Biology 2001 MIT Press Cambridge, MA 1 29
51. R. Larsson, L. Bengtsson, K. Henriksson, and J. Sparks The interorganizational learning dilemma: collective knowledge development in strategic alliances Organizational Science 9 1998 285 305
52. A. Lawler Broad-Novartis venture promises a no-strings, public gene database Science 306 2004 795
53. N. Le Novre, and M. Donizelli The molecular pages of the mesotelencephalic dopamine consortium (DopaNet) BMC Bioinformatics 5 2004 1 9
54. S. Lee, B. Yoon, and Y. Park An approach to discovering new technology opportunities: keyword-based patent map approach Technovation 29 2009 481 497
55. J.D. Linton, and S. Walsh Acceleration and extension of opportunity recognition for nanotechnologies and other emerging technologies International Small Business Journal 26 2008 83 99
56. J.D. Linton, and S. Walsh Integrating innovation and learning curve theory: an enabler for moving nanotechnologies and other emerging process technologies into production R&D Management 34 2004 513 522
57. G. Matthijs Patenting genes may slow down innovation and delay availability of cheaper genetic tests British Medical Journal 329 2004 1358 1360
58. E. Masood Consortium plans free SNP map of human genome Nature 398 1999 545 546
59. R. Merges Property rights theory and the commons: the case of scientific research Scientific Innovation, Philosophy and Public Policy 13 1996 145 167
60. R. Merton Priorities in scientific discovery: a chapter in the sociology of science American Sociological Review 22 1957 635 659
61. R.K. Merton, and R. Lewis The competitive pressures (I): the race for priority Impact of Science on Society 21 1971 151 161
62. T.C. Meyers, T.A. Turano, D.A. Greenhalgh, and P.R.H. Waller Patent protection for protein structures and databases Nature Structural Biology, Structural Genomics Supplement 2000 950 952
63. B. Munos Can open-source drug R&D repower pharmaceutical innovation? Clinical Pharmacology and Therapeutics 87 5 2010 534 536
64. N. Murovec, and I. Prodan Absorptive capacity, its determinants, and influence on innovation output: cross-cultural validation of the structural model Technovation 29 2009 859 872
65. R. Mustachi, S. Hohmann, and J. Nielsen Yeast systems biology to unravel the network of life Yeast 23 2006 227 238
66. NAAR launches largest Autism genetics study. AutismSpeaks.org, July 2004.
67. S.L. Newbert, S. Gopalakrishnan, and B.A. Kirchhoff Looking beyond resources: exploring the importance of entrepreneurship to firm-level competitive advantage in technologically intensive industries Technovation 28 2009 6 19
68. NIGMS awards 35 million to UCSD-led consortium to map metabolic pathways in cells. NIGMS, August 2003.
69. T. Nikulainen, and C. Palmberg Transferring science-based technologies to industrydoes nanotechnology make a difference? Technovation 30 2010 3 11
70. Osteoarthritis initiative releases first data. NIH News, August 2006.
71. E. Ostrom, R. Gardner, and J. Walker Rules, Games and Common-Pool Resources 1994 The University of Michigan Press Ann Arbor, MI
72. Petersen, M. Big pharmas golden eggs. Washington Post, April 2008.
73. W.W. Powell, K.K. Koput, and L. Smith-Doerr Inter-organizational collaboration and the locus of innovation: network of learning in biotechnology Administrative Science Quarterly 41 1996 116 145
74. W.W. Powell, and J. Owen-Smith Universities and the market for intellectual property in the life sciences Journal of Policy Analysis and Management 17 1998 253 277
75. Principles and guidelines for sharing of biomedical research resources. NIH, December 1999.
76. Public-private partnership forms the Biomarkers Consortium to advance the science of personalized medicine. Innovation.org, October 2006.
77. Publicprivate partnership launches Osteoarthritis initiative. NIH News, July 2005.
78. A.K. Rai, and J. Boyle Synthetic biology: caught between property rights, the public domain, and the commons PLoS Biology 5 2007 389 392
79. A.K. Rai, and R.S. Eisenberg BayhDole reform and the progress of biomedicine Law and Contemporary Problems 66 2003 289 314
80. J. Reppy A biomedical militaryindustrial complex? Technovation 28 12 2008 802 811
81. P. Ritala, and P. Hurmelinna-Laukkanen Whats in it for me? Creating and appropriating value in innovation-related coopetition Technovation 29 2009 819 828
82. RNAi consortium to accelerate genetic research. Whitehead Institute for Biomedical Research, March 2005.
83. A. Romig, A. Baker, J. Johannes, T. Zipperian, K. Eijkel, B. Kirchhoff, H.S. Mani, C.N.R. Rao, and S. Walsh An introduction to nanotechnology policy: opportunities and constraints for emerging and established economies Technological Forecasting and Social Change 74 2007 1634 1642
84. E.E. Schadt, S.A. Monks, and S.H. Friend A new paradigm for drug discovery: integrating clinical, genetic and genomic and molecular phenotype data to identify drug targets Drug Discovery and Design 31 2003 437 443
85. F.M. Scherer The economics of human gene patent Academic Medicine 77 2002 1348 1367
86. S. Scotchmer Innovation and Incentives 2004 MIT Press Cambridge, MA
87. S. Scotchmer Standing on the shoulders of giants: cumulative research and the patent law The Journal of Economic Perspectives 5 1991 29 41
88. S. Scotchmer, and J. Green Novelty and disclosure in patent law RAND Journal of Economics 21 1990 131 145
89. J. Senker, and M. Sharp Organizational learning in cooperative alliances: some case studies in biotechnology Technology Analysis and Strategic Management 9 1997 35 51
90. C. Shapiro Navigating the patent thickets: cross-licenses, Patent pools, and standard-setting A. Jaffe, J. Lerner, S. Stern, Innovation Policy and the Economy 2001 NBER
91. Sharing data from large-scale biological research projects: a system of tripartite responsibility. Wellcome Trust, January 2003.
92. C. Staropoli Cooperation in R&D in the pharmaceutical industrythe network as an organizational innovation governing technological innovation Technovation 18 1998 13 23
93. SYMBIONIC and lay line genomics. Lay Line Genomics, September 2004.
94. R. Taussig, R. Ranganathan, E.M. Ross, and A.G. Gilman Overview of the alliance for cellular signaling Nature 420 2002 703 706
95. D.J. Teece Profiting for technological innovation: implications for integration, collaboration, licensing and public policy Research Policy 15 1986 785 805
96. T.C. Terwilliger The TB structural genomics consortium: a resource for Mycobacterium tuberculosis biology Tuberculosis 83 2003 223 249
97. The Biomarkers Consortium website launched for concept submissions and possible funding. Medical News Today, July 2007.
98. The International HapMap Project Nature 426 2003 789 796
99. The International Receptor Tyrosine Kinase Networks Consortium Executive Committee. White Paper, 2005.
100. The Meso-telencephalic Dopamine Consortium (DopaNet) brochure. European Science Foundation.
101. I. Thukral, J. Von Ehr, S. Walsh, A. Greon, P. Van de Sijde, and K.A. Adham Entrepreneurship, emerging technologies, emerging markets International Small Business Journal 26 2008 101 116
102. N. Thumm Patents for genetic inventions: a tool to promote technological advance or a limitation for upstream inventions? Technovation 25 2004 1410 1417
103. G.A. Thorisson, and L.D. Stein The SNP Consortium website: past, present and future Nucleic Acids Research 31 2003 124 127
104. D. Tolstoy, and H. Agndal Network resource combinations in the international venturing of small biotech firms Technovation 30 2010 24 36
105. US Human Epigenome Project Environmental Health Perspectives 114 2006 165 A
106. T. van der Valk, E.H.M. Moors, and M.T.H. Meeus Conceptualizing patterns in the dynamics of emerging technologies: the case of biotechnology developments in the Netherlands Technovation 29 2009 247 264
107. J. Wagner Open-minded to Open Innovation and Precompetitive Collaboration Clinical Pharmacology and Therapeutics 87 5 2010 511 515
108. J.A. Wagner, M. Prince, E.C. Wright, M.M. Ennis, J. Kochan, D.J. Nunez, B. Schneider, M.-D. Wang, Y. Chen, S. Ghosh, B.J. Musser, and M.T. Vassileva The Biomarkers Consortium: practice and pitfalls of Open-Source Precompetitive Collaboration Clinical Pharmacology and Therapeutics 87 5 2010 539 542
109. J.P. Walsh, A. Arora, and W.M. Cohen Effects of research tool patents and licensing on biomedical innovation Patents in the Knowledge-based Economy 2003 The National Academies Press Washington, DC pp. 285340
110. S. Walsh Roadmapping a disruptive technology: a case studythe emerging microsystems and top-down nanosystems Industry Technological Forecasting and Social Change 71 2004 161 185
111. S. Walsh, B. Kirchhoff, and S. Newbert Differentiating market strategies for disruptive technologies IEEE Transactions on Engineering Management 49 2002 341 351
112. J. Weigelt The case for open-access chemical biology EMBO Reports 10 1 2009 941 945
113. A.R. Williamson Creating a structural genomics consortium Nature Structural Biology 7 2000 953
114. J. Woodcock Precompetitive research: a new prescription for drug development? Clinical Pharmacology and Therapeutics 87 5 2010 521 523
115. K. Yin Case Study Research Design and Methods third ed 2003 Sage Publications Thousand Oakes, CA
116. X.L. Yin, and E.J. Zajac The strategy/governance structure fit relationship: theory and evidence in franchising arrangements Strategic Management Journal 25 2004 365 383
117. www.accelrys.com
118. www.afcs.org
119. www.autismspeaks.org
120. www.betacell.org
121. www.biomarkersconsortium.org
122. www.bio.org
123. www.broad.mit.edu
124. www.cellmigration.org
125. www.doe-mbi.ucla.edu/TB
126. www.dopanet.org
127. www.epigenome.org
128. www.functionalglycomics.org
129. www.genome.gov
130. www.gmm.gu.se/YSBN/
131. www.hapmap.org
132. imex.sourceforge.net
133. www.internationalregulomeconsortium.ca
134. www.intgen.org
135. www.intlgenome.org
136. www.lipidmaps.org
137. www.malariagen.net
138. www.naar.org
139. www.oai.ucsf.edu
140. www.openbiosystems.com
141. www.phrma.org
142. www.rcsb.org
143. www.rtkconsort.org
144. www.sanger.ac.uk
145. www.scienceofcollaboratories.org
146. www.sgc.utoronto.ca
147. snp.cshl.org
148. www.symbionicproject.org
149. www.systembiologie.de
150. www.uspto.gov